BioRestorative Therapies, Inc. (BRTX) Balance Sheet
BRTX balance sheet, 2025
December 31, 2025 · U.S. dollars$4.1M assets = $3.7M liabilities + $356,744 equity
Both columns are drawn to the same scale: what BRTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BRTX financial health
Current ratio0.84
Tight · current assets cover current liabilities 0.84×
Equity / assets8.7%
Thin equity · of assets funded by shareholders
Goodwill & intangibles13.1%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal 2025.
BRTX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.6M2016 | $4.1M2025 | +11.1%/yr | |
| Total liabilities | $6.6M2016 | $3.7M2025 | −6.1%/yr | |
| Shareholders’ equity | −$5.0M2016 | $356,7442025 | — | |
| Cash & short-term investments | $31,8222016 | $3.0M2025 | +65.4%/yr | |
| Total debt | $2.2M2016 | $162,3172024 | −27.6%/yr | |
| Net cash (debt) | −$2.1M2016 | $10.6M2024 | +$12.7M | |
| Working capital | −$5.8M2016 | −$586,0292025 | +$5.2M | |
| Book value per share | $21.982024 | $0.792025 | −96.4%/yr | |
| Current ratio | 0.012016 | 0.842025 | +0.83 | |
| Debt / equity | 0.032021 | 0.022024 | −0.01 | |
| Shares outstanding | 388K2024 | 450K2025 | +15.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BRTX assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
BRTX liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
BRTX debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BRTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $3.0M | $10.7M | $11.1M | $14.7M | $21.0M | $3.1M | $1,664 | $117,523 | $451,680 | $31,822 |
| Cash & equivalents | $1.5M | $547,890 | $884,377 | $1.7M | $21.0M | $3.1M | $1,664 | $117,523 | $451,680 | $31,822 |
| Short-term investments | $1.4M | $10.2M | $10.2M | $13.0M | $0 | — | — | — | — | — |
| Receivables | $15,500 | $188,400 | $19,300 | $16,000 | $5,000 | $17,000 | $32,000 | $29,000 | $38,000 | $6,000 |
| Inventory | $0 | $0 | $1 | $1 | $0 | $1 | $0 | $0 | $0 | $0 |
| Other current assets | $168,440 | $223,230 | $305,230 | $363,081 | $436,181 | $105,406 | $35,199 | $34,464 | $30,030 | $23,854 |
| Total current assets | $3.1M | $11.1M | $11.4M | $15.1M | $21.5M | $3.2M | $68,863 | $180,987 | $519,710 | $61,676 |
| Property, plant & equipment (net) | $358,767 | $362,936 | $507,502 | $502,762 | $395,798 | $495,763 | $658,296 | $175,235 | $327,847 | $508,594 |
| Goodwill & intangible assets | $534,198 | $623,945 | $713,692 | $803,438 | $589,740 | $664,268 | $739,164 | $814,059 | $888,950 | $963,845 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $49,808 | $148,697 | $0 | $1 | $0 | $0 | $0 | $22,100 | $22,100 | $45,900 |
| Total assets | $4.1M | $12.3M | $12.6M | $16.4M | $22.5M | $4.3M | $1.5M | $1.2M | $1.8M | $1.6M |
| Liabilities | ||||||||||
| Accounts payable | $1.3M | $483,070 | $189,389 | $170,902 | $50,827 | $118,851 | $2.0M | $1.9M | $2.5M | $2.3M |
| Short-term debt | — | $324,634 | $162,317 | $139,328 | $178,025 | $158,371 | $7.2M | $3.6M | $3.5M | $1.9M |
| Deferred revenue | — | — | $1 | — | — | $3.6M | — | $2.6M | $2.2M | — |
| Total current liabilities | $3.7M | $3.7M | $2.6M | $6.0M | $363,822 | $1.0M | $13.7M | $9.3M | $8.4M | $5.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $191,030 | $4.3M | $0 | $523,894 | $194,282 | $297,756 |
| Lease obligations | — | $0 | $162,317 | $301,645 | $420,700 | $521,890 | $607,355 | — | — | — |
| Other long-term liabilities | $0 | $0 | $0 | $162,317 | $301,645 | $363,519 | $521,890 | $54,637 | $47,591 | $437,681 |
| Total liabilities | $3.7M | $3.7M | $2.6M | $6.1M | $856,497 | $5.7M | $14.2M | $9.8M | $8.6M | $6.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $887 | $692 | $471 | $369 | $353 | $72 | $7,787 | $11,728 | $6,112 | $4,699 |
| Retained earnings (deficit) | −$169.9M | −$155.7M | −$146.7M | −$136.3M | −$134.1M | −$89.8M | −$78.6M | −$63.9M | −$51.4M | −$42.0M |
| Accumulated other comprehensive income | — | — | $0 | — | — | $0 | — | −$690,041 | $0 | — |
| Total shareholders' equity | $356,744 | $8.5M | $10.0M | $10.3M | $21.6M | −$1.3M | −$12.8M | −$8.6M | −$6.8M | −$5.0M |
| Key figures | ||||||||||
| Total debt | — | $162,317 | $162,317 | $301,645 | $670,700 | $4.8M | $7.8M | $4.1M | $3.7M | $2.2M |
| Net cash (debt) | — | $10.6M | $10.9M | $14.4M | $20.4M | −$1.7M | −$7.8M | −$4.0M | −$3.2M | −$2.1M |
| Working capital | −$586,029 | $7.4M | $8.8M | $9.1M | $21.1M | $2.1M | −$13.7M | −$9.1M | −$7.8M | −$5.8M |
| Tangible book value | −$177,454 | $7.9M | $9.3M | $9.5M | $21.0M | −$2.0M | −$13.5M | −$9.5M | −$7.7M | −$6.0M |
| Book value per share | $0.79 | $21.98 | — | — | — | — | — | — | — | — |
| Shares outstanding | 450K | 388K | — | — | — | — | — | — | — | — |
| Current ratio | 0.84 | 2.97 | 4.37 | 2.53 | 59.01 | 3.05 | 0.01 | 0.02 | 0.06 | 0.01 |
| Quick ratio | 0.80 | 2.91 | 4.25 | 2.47 | 57.81 | 2.95 | 0.00 | 0.02 | 0.06 | 0.01 |
| Debt / equity | — | 0.02 | 0.02 | 0.03 | 0.03 | — | — | — | — | — |
| Equity / assets | 8.7% | 69.5% | 79.3% | 62.6% | 96.2% | −30.6% | −871.3% | −724.7% | −388.7% | −316.5% |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $3.6M | $3.0M | $4.5M | $7.4M | $9.1M | $10.7M | $13.1M | $14.7M | $16.4M | $11.1M | $12.2M | $11.6M |
| Cash & equivalents | $3.1M | $1.5M | $602,444 | $1.6M | $1.2M | $547,890 | $1.5M | $2.3M | $1.2M | $884,377 | $2.4M | $1.8M |
| Short-term investments | $479,351 | $1.4M | $3.9M | $5.8M | $7.9M | $10.2M | $11.6M | $12.4M | $15.3M | $10.2M | $9.8M | $9.8M |
| Receivables | $13,300 | $15,500 | $13,400 | $15,000 | $25,000 | $188,400 | $165,000 | $27,400 | $35,000 | $19,300 | $39,300 | $25,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $1 | $1 |
| Other current assets | $194,378 | $168,440 | $196,746 | $201,871 | $217,400 | $223,230 | $256,078 | $295,861 | $316,963 | $305,231 | $325,930 | $403,558 |
| Total current assets | $3.8M | $3.1M | $4.7M | $7.6M | $9.4M | $11.1M | $13.5M | $15.0M | $16.8M | $11.4M | $12.6M | $12.0M |
| Property, plant & equipment (net) | $328,810 | $358,767 | $309,498 | $339,681 | $369,992 | $362,936 | $418,131 | $423,953 | $480,410 | $507,502 | $461,036 | $497,808 |
| Goodwill & intangible assets | $511,761 | $534,198 | $556,634 | $579,071 | $601,508 | $623,945 | $646,381 | $668,818 | $691,255 | $713,692 | $736,128 | $758,565 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $49,808 | $76,557 | $0 | $0 | $148,697 | $0 | $22,380 | $9,538 | $0 | $0 | $0 |
| Total assets | $4.6M | $4.1M | $5.6M | $8.5M | $10.3M | $12.3M | $14.6M | $16.1M | $18.0M | $12.6M | $13.8M | $13.3M |
| Liabilities | ||||||||||||
| Accounts payable | $666,898 | $1.3M | $859,898 | $609,931 | $599,500 | $483,070 | $401,379 | $215,920 | $230,902 | $189,389 | $227,355 | $276,048 |
| Short-term debt | $34,515 | — | — | — | — | — | $42,414 | $83,580 | $123,536 | — | $156,310 | $150,480 |
| Deferred revenue | — | — | — | — | $150,000 | — | — | $80,700 | $1 | — | — | — |
| Total current liabilities | $1.6M | $3.7M | $3.4M | $3.7M | $4.2M | $3.7M | $4.6M | $5.3M | $3.4M | $2.6M | $932,619 | $812,853 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | — | — | $0 | $42,414 | $83,580 | $123,536 | $162,317 | $198,724 | $234,060 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $42,414 | $83,580 |
| Total liabilities | $1.6M | $3.7M | $3.4M | $3.7M | $4.2M | $3.7M | $4.6M | $5.3M | $3.4M | $2.6M | $975,033 | $896,433 |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2,548 | $887 | $797 | $797 | $750 | $692 | $692 | $692 | $677 | — | $468 | $399 |
| Retained earnings (deficit) | −$172.1M | −$169.9M | −$166.7M | −$163.7M | −$161.0M | −$155.7M | −$154.0M | −$153.0M | −$148.9M | −$146.7M | −$164.2M | −$161.3M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | −$13,982 | $0 | — | $0 | — |
| Total shareholders' equity | $3.0M | $356,744 | $2.2M | $4.8M | $6.1M | $8.5M | $10.0M | $10.8M | $14.5M | $10.0M | $12.8M | $12.4M |
| Key figures | ||||||||||||
| Total debt | $34,515 | — | — | — | — | — | $42,414 | $83,580 | $123,536 | — | $198,724 | $234,060 |
| Net cash (debt) | $3.6M | — | — | — | — | — | $13.0M | $14.6M | $16.3M | — | $12.0M | $11.4M |
| Working capital | $2.2M | −$586,029 | $1.3M | $3.9M | $5.2M | $7.4M | $8.9M | $9.7M | $13.3M | $8.8M | $11.7M | $11.2M |
| Tangible book value | $2.5M | −$177,454 | $1.7M | $4.3M | $5.5M | $7.9M | $9.3M | $10.1M | $13.8M | $9.3M | $12.1M | $11.6M |
| Book value per share | $3.41 | $0.80 | $4.84 | $11.09 | $14.71 | $24.66 | $24.61 | $26.59 | $43.48 | $2.13 | $20.81 | — |
| Shares outstanding | 886K | 444K | 456K | 437K | 418K | 346K | 406K | 406K | 334K | 4.7M | 616K | — |
| Current ratio | 2.35 | 0.84 | 1.37 | 2.07 | 2.24 | 2.97 | 2.95 | 2.82 | 4.86 | 4.37 | 13.51 | 14.82 |
| Quick ratio | 2.23 | 0.80 | 1.31 | 2.01 | 2.19 | 2.91 | 2.89 | 2.76 | 4.77 | 4.25 | 13.17 | 14.32 |
| Debt / equity | 0.01 | — | — | — | — | — | 0.00 | 0.01 | 0.01 | — | 0.02 | 0.02 |
| Equity / assets | 65.2% | 8.7% | 39.1% | 56.9% | 59.5% | 69.5% | 68.6% | 67.0% | 80.8% | 79.3% | 92.9% | 93.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.
BRTX financial position
At the end of fiscal 2025 (December 31, 2025), BioRestorative Therapies had total assets of $4.1 million (down 66.8% from a year earlier), total liabilities of $3.7 million and shareholders' equity of $0.4 million. Its current ratio was 0.84. In the latest quarter (ended March 31, 2026) total assets were $4.6 million and equity $3.0 million.
Related: BRTX income statement, BRTX cash flow statement, BRTX key metrics. See the BRTX stock overview for the latest quote and news.
BRTX balance sheet FAQ
What are BioRestorative Therapies's total assets?
BioRestorative Therapies reported total assets of $4.1 million at the end of fiscal 2025 (December 31, 2025), compared with $12.3 million a year earlier.
How much cash does BioRestorative Therapies have?
BioRestorative Therapies held $3.0 million in cash and short-term investments at the end of fiscal 2025.
What is BioRestorative Therapies's book value?
BioRestorative Therapies's shareholders' equity (book value) was $0.4 million at the end of fiscal 2025, or $0.79 per share.
What is BioRestorative Therapies's current ratio?
BioRestorative Therapies had current assets of $3.1 million and current liabilities of $3.7 million, a current ratio of 0.84 (current liabilities exceed current assets).
How much goodwill does BioRestorative Therapies have?
BioRestorative Therapies carried $0.5 million of goodwill and intangible assets, 13.1% of total assets, at the end of fiscal 2025.